The ROMedVR project is pioneering advancements in pre-surgical planning for Congenital Heart Diseases (CHDs) through the integration of Computational Fluid Dynamics (CFD), Reduced Order Modeling, and Virtual Reality (VR). This interdisciplinary approach aims to enhance surgical decision-making by enabling patient-specific, optimized interventions, thereby improving clinical outcomes.

Consortium and Contributions

The project is driven by a multidisciplinary consortium of leading organizations:

🔹 ENGYS – Advancing high-fidelity CFD simulations for cardiovascular modeling.
🔹 RBF Morph – Spearheading VR integration to facilitate intuitive and interactive surgical planning.
🔹 InSilicoTrials – Assessing and commercializing VR-based navigation systems for preoperative strategies.
🔹 Fondazione Toscana Gabriele Monasterio (FTGM) – Providing clinical expertise in CHD treatment and patient care.

Project Timeline and Funding

Officially initiated in November 2024, the ROMedVR project is projected to transform CHD surgical planning by October 2025. With a total budget of €426,644.42 and secured funding of €319,010.23, this initiative is set to redefine the landscape of pediatric cardiovascular surgery. We take pride in contributing to the future of precision medicine and surgical innovation.

Read more in the Avicenna Alliance newsletter.